Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Immuron Seeks Trading Halt Pending Announcement On Phase 2 Imm-124E Clinical Trial Top-Line Results

March 5 (Reuters) - Immuron Ltd  IMC.AX :
    * SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PHASE 2
IMM-124E
CLINICAL TRIAL TOP-LINE RESULTS


Further company coverage:  IMC.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Immuron

See all news